Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Menopavza in metabolni sindrom
Authors:ID Groti Antonič, Kristina (Author)
Files:.pdf PDF - Presentation file, download (388,15 KB)
MD5: F074EBE876F31D67802F3EA9ED909715
 
Language:Slovenian
Typology:1.02 - Review Article
Organization:Logo SFD - Slovenian Pharmaceutical Society
Abstract:Metabolni sindrom je skupek povezanih kliničnih in presnovnih dejavnikov, ki napovedujejo tveganje za nastanek sladkorne bolezni tipa 2 in srčno-žilne bolezni. Metabolni sindrom vključuje visceralno debelost, moteno presnovo glukoze, aterogeno dislipidemijo in arterijsko hipertenzijo. Povečana prevalenca metabolnega sindroma v menopavzi je posledica izgube proaktivne vloge estrogenov in povečanih koncentracij androgenov v obtoku, kar povzroči porazdelitev telesne maščobe in razvoj visceralne debelosti. Metabolni sindrom lahko vpliva tudi na tveganje za nastanek raka endometrija in dojke, osteoporoze, kronične ledvične bolezni, srčno-žilnih zapletov ter zmanjšanja kakovosti življenja v menopavzi. Načrtovano hujšanje, omejitev kalorij in telesna aktivnost so povezani z zmanjšanim tveganjem za bolezni endometrija. Poleg sprememb življenjskega sloga se lahko v primeru odsotnosti kontraindikacij predpiše zdravilo metformin, ki zmanjšuje metabolni sindrom, znižuje raven inzulina pri ženskah po menopavzi in je močan zaviralec proliferacije rakavih celic endometrija. Še vedno pa je pri obvladovanju simptomov in nekaterih posledic menopavze najučinkovitejše hormonsko nadomestno zdravljenje.
Keywords:debelost, menopavza, metabolni sindrom, metformin, sladkorna bolezen tipa 2
Publication status:Published
Publication version:Version of Record
Publication date:01.05.2025
Year of publishing:2025
Number of pages:str. 99-108
Numbering:Letn. 76, Št. 2
PID:20.500.12556/DiRROS-23027 New window
UDC:618.173
ISSN on article:2536-4316
COBISS.SI-ID:242346243 New window
Note:Nasl. z nasl. zaslona; Besedilo v slov.; Opis vira z dne 13. 7. 2025;
Publication date in DiRROS:17.07.2025
Views:431
Downloads:145
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Farmacevtski vestnik : strokovno glasilo slovenske farmacije
Publisher:Slovensko farmacevtsko društvo
ISSN:2536-4316
COBISS.SI-ID:288686336 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:English
Title:Menopause and metabolic syndrome
Abstract:Metabolic syndrome is a cluster of associated clinical and metabolic risk factors that predict the risk of type 2 diabetes and cardiovascular disease. Metabolic Syndrome includes visceral obesity, impaired glucose metabolism, atherogenic dyslipidemia, and arterial hypertension. The increased prevalence of metabolic syndrome in menopause is due to the loss of the proactive role of estrogens and increased androgens in the circulation, resulting in redistribution of body fat and development of visceral obesity. Metabolic syndrome can also affect the risk of breast and endometrial cancer, osteoporosis, chronic kidney disease, cardiovascular diseases and reduce quality of life during menopause. Intentional weight loss, calorie restric
Keywords:menopause, metabolic syndrome, metformi, obesity, type 2 diabetes


Collection

This document is a part of these collections:
  1. Farmacevtski vestnik

Back